Logo Astrana Health, Inc.

Astrana Health, Inc. (ASTH) stock: analyst price target and their real reliability

Live quote · data updated Aug 28, 2026
Astrana Health, Inc. · Health Care · ref. ETF XLV · 49 calls · price $38.41
🔔Price alertsCreate an alert →
What the company does: Astrana Health, Inc., which rebranded from Apollo Medical Holdings, Inc.

📈 Astrana Health, Inc. (ASTH) stock price

$38.41+22.6% over range
Aug 28, 25low $18.16 · high $49.81Aug 27, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
100% recommend buying · 6 analysts
📊 JPI status : Astrana Health, Inc. is no longer in our current JPI rankings, but appeared in the past (2025) — its upside may be behind it. See the stocks picked in 2025 →

🎯 ASTH price target & analyst consensusprice $38.41

The price target · all analysts combined (6 targets)
Highest target · 1 firm of 6$65+69.2%
Median target · of 6 targets$51.5+34.1%
Lowest target · 1 firm of 6$40+4.1%
Current price$38.41
Where these 6 targets sit · versus the current price · 1 target per firm, last 6 months
Above the price 6100% $40 ↔ $65
⭐ What the most reliable analysts say

No reliable analyst is bullish on this stock right now. A “reliable” analyst is a firm that, on this sector, hits more than 55% of its targets and beats its sector. None of them sees upside here — which is exactly why this stock is in no JPI selection.

The consensus · 6 ratings (last 6 months)
Strong Buy00%
Buy6100%
Hold00%
Sell00%
Strong Sell00%
Go deeper on the analysts
All analysts (the consensus)  ·  vs  ·  the best (those who've been right)
💬 A question about Astrana Health, Inc.? The JPI assistant answers using our backtest data.

🔎 Detailed analyses

✅ Historical analyst reliability on ASTH

Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.

Firm % right i Gain vs sector i Calls i
Lake Street 100% +26.3% 2
BTIG  50% +18.3% 2
Stifel  20% -29.6% 5
B of A Securities  0% -11.1% 2
Truist Securities  0% -29.6% 4
Baird  0% -33.0% 4

📊 What $1,000 invested in Astrana Health, Inc. would be worth › open the full page

In short — $1,000 invested in Astrana Health, Inc. 10 years ago would be worth $10,316 today, i.e. +26%/yr on average. Best year: 2021 (+302%), worst: 2022 (-60%). Price performance, excluding dividends.

If I'd invested $1,000 in Astrana Health, Inc.

InvestmentWorth todayGain
1 years ago$1,554+55%
3 years ago$1,656+66%
5 years ago$2,682+168%
→ See Astrana Health, Inc.'s full return history + gain calculator

Return by year (Astrana Health, Inc.)

YearReturn$1,000 invested at year start
2026 (YTD)+98%$1,975 (+98%)
2025-21%$1,554 (+55%)
2024-18%$1,279 (+28%)
→ See Astrana Health, Inc.'s full return history + gain calculator
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.

📰 Recent news on Astrana Health, Inc.

Loading news…

📋 All analyst calls on ASTH

▲ Buy · 🎯$55
Price at call : $35.79 — upside +54%
Today : $38.41 — upside +43%
🎯 on ASTH : 0% (4 calls matureds) · 📊 on Health : 37.6% · -0.8% (165 calls)
in progress (365j)
matures : Aug 11, 27
Barclays 
Aug 7, 26
▲ Overweight · 🎯$53
Price at call : $35.76 — upside +48%
Today : $38.41 — upside +38%
🎯 on ASTH : no call matured yet · 📊 on Health : 37.3% · -8.4% (150 calls)
in progress (365j)
matures : Aug 7, 27
TD Cowen 
Jul 14, 26
▲ Buy · 🎯$50
Price at call : $47.04 — upside +6%
Today : $38.41 — upside +30%
🎯 on ASTH : 0% (1 call matured) · 📊 on Health : 55.3% · -0.8% (38 calls)
in progress (365j)
matures : Jul 14, 27
BTIG 
Jul 14, 26
▲ Buy · 🎯$65
Price at call : $49 — upside +33%
Today : $38.41 — upside +69%
🎯 on ASTH : 50% (2 calls matureds) · 📊 on Health : 46.2% · +19.8% (65 calls)
in progress (365j)
matures : Jul 14, 27
BTIG 
Jun 2, 26
▲ Buy · 🎯$50
Price at call : $36.91 — upside +35%
Today : $38.41 — upside +30%
🎯 on ASTH : 50% (2 calls matureds) · 📊 on Health : 46.2% · +19.8% (65 calls)
in progress (365j)
matures : Jun 2, 27
Barclays 
May 26, 26
▲ Overweight · 🎯$50
Price at call : $38.52 — upside +30%
Today : $38.41 — upside +30%
🎯 on ASTH : no call matured yet · 📊 on Health : 37.3% · -8.4% (150 calls)
in progress (365j)
matures : May 26, 27
▲ Buy · 🎯$47
Price at call : $38.26 — upside +23%
Today : $38.41 — upside +22%
🎯 on ASTH : 0% (4 calls matureds) · 📊 on Health : 37.6% · -0.8% (165 calls)
in progress (365j)
matures : May 14, 27
TD Cowen 
May 12, 26
▲ Buy · 🎯$45
Price at call : $39.76 — upside +13%
Today : $38.41 — upside +17%
🎯 on ASTH : 0% (1 call matured) · 📊 on Health : 55.3% · -0.8% (38 calls)
in progress (365j)
matures : May 12, 27
See the other 41 calls, newest to oldest
Barclays 
May 11, 26
■ Equal-Weight neutral · not a buy · 🎯$37
Price at call : $37.97 — gap to target -3%
Today : $38.41 — gap to target -4%
🎯 on ASTH : no call matured yet · 📊 on Health : 37.3% · -8.4% (150 calls)
in progress (365j)
matures : May 11, 27
BTIG 
May 8, 26
▲ Buy · 🎯$50
Price at call : $39.3 — upside +27%
Today : $38.41 — upside +30%
🎯 on ASTH : 50% (2 calls matureds) · 📊 on Health : 46.2% · +19.8% (65 calls)
in progress (365j)
matures : May 8, 27
Needham 
May 8, 26
▲ Buy · 🎯$41
Price at call : $39.3 — upside +4%
Today : $38.41 — upside +7%
🎯 on ASTH : no call matured yet · 📊 on Health : 39% · -2.9% (397 calls)
in progress (365j)
matures : May 8, 27
Baird 
Apr 15, 26
▲ Outperform · 🎯$40
Price at call : $29.23 — upside +37%
Today : $38.41 — upside +4%
🎯 on ASTH : 0% (4 calls matureds) · 📊 on Health : 37.8% · -2.8% (82 calls)
in progress (365j)
matures : Apr 15, 27
▲ Buy · 🎯$38
Price at call : $24.6 — upside +54%
Today : $38.41 — upside -1%
🎯 on ASTH : 0% (4 calls matureds) · 📊 on Health : 37.6% · -0.8% (165 calls)
in progress (365j)
matures : Mar 13, 27
BTIG 
Feb 2, 26
▲ Buy · 🎯$40
Price at call : $22.32 — upside +79%
Today : $38.41 — upside +4%
🎯 on ASTH : 50% (2 calls matureds) · 📊 on Health : 46.2% · +19.8% (65 calls)
in progress (365j)
matures : Feb 2, 27
Needham 
Dec 12, 25
▲ Buy · 🎯$28
Price at call : $23.47 — upside +19%
Today : $38.41 — upside -27%
🎯 on ASTH : no call matured yet · 📊 on Health : 39% · -2.9% (397 calls)
in progress (365j)
matures : Dec 12, 26
Jefferies 
Nov 25, 25
▲ Buy · 🎯$37
Price at call : $23.05 — upside +61%
Today : $38.41 — upside -4%
🎯 on ASTH : 0% (1 call matured) · 📊 on Health : 50% · +9.9% (136 calls)
in progress (365j)
matures : Nov 25, 26
Barclays 
Nov 24, 25
■ Equal-Weight neutral · not a buy · 🎯$26
Price at call : $22.6 — gap to target +15%
Today : $38.41 — gap to target -32%
🎯 on ASTH : no call matured yet · 📊 on Health : 37.3% · -8.4% (150 calls)
in progress (365j)
matures : Nov 24, 26
TD Cowen 
Nov 10, 25
▲ Buy · 🎯$35
Price at call : $23.8 — upside +47%
Today : $38.41 — upside -9%
🎯 on ASTH : 0% (1 call matured) · 📊 on Health : 55.3% · -0.8% (38 calls)
in progress (365j)
matures : Nov 10, 26
BTIG 
Nov 7, 25
▲ Buy · 🎯$45
Price at call : $22.43 — upside +101%
Today : $38.41 — upside +17%
🎯 on ASTH : 50% (2 calls matureds) · 📊 on Health : 46.2% · +19.8% (65 calls)
in progress (365j)
matures : Nov 7, 26
Barclays 
Apr 1, 25
■ Equal-Weight neutral · not a buy · 🎯$36
Price at call : $29.86 — gap to target +21%
Today : $38.41 — gap to target -6%
🎯 on ASTH : no call matured yet · 📊 on Health : 37.3% · -8.4% (150 calls)
in progress (365j)
matures : Apr 1, 26
▲ Buy · 🎯$46
Price at call : $31.51 — upside +46%
Today : $38.41 — upside +20%
Expected +46% · Actual -23% · Reason (≥ +15%) : ✗ No
🎯 on ASTH : 0% (4 calls matureds) · 📊 on Health : 37.6% · -0.8% (165 calls)
-23.3%
stock -23% · XLV -0%
matured Mar 18, 26
▲ Buy · 🎯$49
Price at call : $27.19 — upside +80%
Today : $38.41 — upside +28%
Expected +80% · Actual -8% · Reason (≥ +15%) : ✗ No
🎯 on ASTH : 0% (2 calls matureds) · 📊 on Health : 51.3% · +3.0% (152 calls)
-7.8%
stock -8% · XLV +3%
matured Mar 4, 26
Baird 
Mar 3, 25
▲ Outperform · 🎯$50
Price at call : $26.48 — upside +89%
Today : $38.41 — upside +30%
Expected +89% · Actual -7% · Reason (≥ +15%) : ✗ No
🎯 on ASTH : 0% (4 calls matureds) · 📊 on Health : 37.8% · -2.8% (82 calls)
-7.4%
stock -7% · XLV +5%
matured Mar 3, 26
Stifel 
Feb 20, 25
▲ Buy · 🎯$56
Price at call : $35.68 — upside +57%
Today : $38.41 — upside +46%
Expected +57% · Actual -44% · Reason (≥ +15%) : ✗ No
🎯 on ASTH : 20% (5 calls matureds) · 📊 on Health : 44.8% · +6.7% (96 calls)
-44.5%
stock -44% · XLV +8%
matured Feb 20, 26
▲ Buy · 🎯$50
Price at call : $30.28 — upside +65%
Today : $38.41 — upside +30%
Expected +65% · Actual -10% · Reason (≥ +15%) : ✗ No
🎯 on ASTH : 0% (4 calls matureds) · 📊 on Health : 37.6% · -0.8% (165 calls)
-10.4%
stock -10% · XLV +11%
matured Jan 13, 26
Baird 
Nov 13, 24
▲ Outperform · 🎯$86
Price at call : $41.91 — upside +105%
Today : $38.41 — upside +124%
Expected +105% · Actual -48% · Reason (≥ +15%) : ✗ No
🎯 on ASTH : 0% (4 calls matureds) · 📊 on Health : 37.8% · -2.8% (82 calls)
-47.7%
stock -48% · XLV +4%
matured Nov 13, 25
TD Cowen 
Oct 14, 24
▲ Buy · 🎯$66
Price at call : $59.64 — upside +11%
Today : $38.41 — upside +72%
Expected +11% · Actual -50% · Reason (≥ +15%) : ✗ No
🎯 on ASTH : 0% (1 call matured) · 📊 on Health : 55.3% · -0.8% (38 calls)
-50.3%
stock -50% · XLV -8%
matured Oct 14, 25
Keybanc 
Oct 11, 24
■ Sector Weight neutral · not a buy
🎯 on ASTH : no call matured yet · 📊 on Health : 25.2% · -18.3% (107 calls)
in progress (365j)
matures : Oct 11, 25
BTIG 
Oct 3, 24
▲ Buy · 🎯$70
Price at call : $59.48 — upside +18%
Today : $38.41 — upside +82%
Expected +18% · Actual -52% · Reason (≥ +15%) : ✗ No
🎯 on ASTH : 50% (2 calls matureds) · 📊 on Health : 46.2% · +19.8% (65 calls)
-51.7%
stock -52% · XLV -4%
matured Oct 3, 25
Baird 
Aug 15, 24
▲ Outperform · 🎯$67
Price at call : $47.7 — upside +40%
Today : $38.41 — upside +74%
Expected +40% · Actual -39% · Reason (≥ +15%) : ✗ No
🎯 on ASTH : 0% (4 calls matureds) · 📊 on Health : 37.8% · -2.8% (82 calls)
-38.5%
stock -39% · XLV -11%
matured Aug 15, 25
▲ Buy · 🎯$59
Price at call : $47.91 — upside +23%
Today : $38.41 — upside +54%
Expected +23% · Actual -40% · Reason (≥ +15%) : ✗ No
🎯 on ASTH : 0% (4 calls matureds) · 📊 on Health : 37.6% · -0.8% (165 calls)
-40.1%
stock -40% · XLV -13%
matured Aug 9, 25
Stifel 
Aug 1, 24
▲ Buy · 🎯$60
Price at call : $49.28 — upside +22%
Today : $38.41 — upside +56%
Expected +22% · Actual -56% · Reason (≥ +15%) : ✗ No
🎯 on ASTH : 20% (5 calls matureds) · 📊 on Health : 44.8% · +6.7% (96 calls)
-55.6%
stock -56% · XLV -12%
matured Aug 1, 25
▲ Buy · 🎯$50
Price at call : $45 — upside +11%
Today : $38.41 — upside +30%
Expected +11% · Actual -45% · Reason (≥ +15%) : ✗ No
🎯 on ASTH : 0% (4 calls matureds) · 📊 on Health : 37.6% · -0.8% (165 calls)
-44.7%
stock -45% · XLV -8%
matured Jul 11, 25
Stifel 
Jun 27, 24
▲ Buy · 🎯$48
Price at call : $40.77 — upside +18%
Today : $38.41 — upside +25%
Expected +18% · Actual -39% · Reason (≥ +15%) : ✗ No
🎯 on ASTH : 20% (5 calls matureds) · 📊 on Health : 44.8% · +6.7% (96 calls)
-39.3%
stock -39% · XLV -8%
matured Jun 27, 25
Baird 
May 30, 24
▲ Outperform · 🎯$54
Price at call : $40.06 — upside +35%
Today : $38.41 — upside +41%
Expected +35% · Actual -38% · Reason (≥ +15%) : ✗ No
🎯 on ASTH : 0% (4 calls matureds) · 📊 on Health : 37.8% · -2.8% (82 calls)
-38.1%
stock -38% · XLV -6%
matured May 30, 25
Stifel 
May 8, 24
▲ Buy · 🎯$45
Price at call : $38.09 — upside +18%
Today : $38.41 — upside +17%
Expected +18% · Actual -12% · Reason (≥ +15%) : ✗ No
🎯 on ASTH : 20% (5 calls matureds) · 📊 on Health : 44.8% · +6.7% (96 calls)
-12.2%
stock -12% · XLV -6%
matured May 8, 25
■ Hold neutral · not a buy · 🎯$44
Price at call : $43.57 — gap to target +1%
Today : $38.41 — gap to target +15%
🎯 on ASTH : 0% (4 calls matureds) · 📊 on Health : 37.6% · -0.8% (165 calls)
in progress (365j)
matures : Mar 1, 25
Jefferies 
Feb 26, 24
▲ Buy · 🎯$50
Price at call : $42.79 — upside +17%
Today : $38.41 — upside +30%
Expected +17% · Actual -17% · Reason (≥ +15%) : ✗ No
🎯 on ASTH : 0% (1 call matured) · 📊 on Health : 50% · +9.9% (136 calls)
-17.3%
stock -17% · XLV +1%
matured Feb 25, 25
▲ Buy · 🎯$55
Price at call : $41.7 — upside +32%
Today : $38.41 — upside +43%
Expected +32% · Actual -14% · Reason (≥ +15%) : ✗ No
🎯 on ASTH : 0% (2 calls matureds) · 📊 on Health : 51.3% · +3.0% (152 calls)
-14.4%
stock -14% · XLV -1%
matured Feb 21, 25
Stifel 
Jan 24, 24
▲ Buy · 🎯$45
Price at call : $36.7 — upside +23%
Today : $38.41 — upside +17%
Expected +23% · Actual +3% · Reason (≥ +15%) : ✗ No
🎯 on ASTH : 20% (5 calls matureds) · 📊 on Health : 44.8% · +6.7% (96 calls)
+3.4%
stock +3% · XLV +4%
matured Jan 23, 25
■ Hold neutral · not a buy · 🎯$41
Price at call : $37.93 — gap to target +8%
Today : $38.41 — gap to target +7%
🎯 on ASTH : 0% (4 calls matureds) · 📊 on Health : 37.6% · -0.8% (165 calls)
in progress (365j)
matures : Dec 21, 24
BTIG 
Oct 17, 23
▲ Buy · 🎯$45
Price at call : $33.24 — upside +35%
Today : $38.41 — upside +17%
Expected +35% · Actual +88% · Reason (≥ +15%) : ✓ Yes
🎯 on ASTH : 50% (2 calls matureds) · 📊 on Health : 46.2% · +19.8% (65 calls)
+88.1%
stock +88% · XLV +17%
matured Oct 16, 24
■ Neutral neutral · not a buy · 🎯$44
Price at call : $38.87 — gap to target +13%
Today : $38.41 — gap to target +15%
🎯 on ASTH : 0% (2 calls matureds) · 📊 on Health : 51.3% · +3.0% (152 calls)
in progress (365j)
matures : Apr 11, 24
Lake Street
Feb 27, 23
▲ Buy · 🎯$60
Price at call : $34.9 — upside +72%
Today : $38.41 — upside +56%
Expected +72% · Actual +25% · Reason (≥ +15%) : ✓ Yes
🎯 on ASTH : 100% (2 calls matureds) · 📊 on Health : 61.5% · +24.8% (26 calls)
+25.4%
stock +25% · XLV +15%
matured Feb 27, 24
Lake Street
Dec 19, 22
▲ Buy · 🎯$40
Price at call : $29.45 — upside +36%
Today : $38.41 — upside +4%
Expected +36% · Actual +27% · Reason (≥ +15%) : ✓ Yes
🎯 on ASTH : 100% (2 calls matureds) · 📊 on Health : 61.5% · +24.8% (26 calls)
+27.1%
stock +27% · XLV +0%
matured Dec 19, 23
William Blair 
Sep 21, 22
▲ Outperform
Actual -27% · Reason (≥ +15%) : ✗ No
🎯 on ASTH : 0% (1 call matured) · 📊 on Health : 32% · -10.8% (25 calls)
-27.3%
stock -27% · XLV +6%
matured Sep 21, 23
Barclays 
Aug 8, 22
■ Equal-Weight neutral · not a buy · 🎯$57
Price at call : $52.95 — gap to target +8%
Today : $38.41 — gap to target +48%
🎯 on ASTH : no call matured yet · 📊 on Health : 37.3% · -8.4% (150 calls)
in progress (365j)
matures : Aug 8, 23
Barclays 
Aug 12, 21
■ Equal-Weight neutral · not a buy · 🎯$92
Price at call : $75.56 — gap to target +22%
Today : $38.41 — gap to target +140%
🎯 on ASTH : no call matured yet · 📊 on Health : 37.3% · -8.4% (150 calls)
in progress (365j)
matures : Aug 12, 22
Dougherty & Co.
Apr 26, 18
▲ Buy · 🎯$25
Price at call : $15.9 — upside +57%
Today : $38.41 — upside -35%
Expected +57% · Actual +24% · Reason (≥ +15%) : ✓ Yes
🎯 on ASTH : 100% (1 call matured) · 📊 unranked overall
+23.9%
stock +24% · XLV +6%
matured Apr 26, 19

Frequently asked questions

Should I buy Astrana Health, Inc. stock?

This isn't buy advice. For Astrana Health, Inc., the analyst consensus is "Buy", with an average price target of $51.50 (+34% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 100% of the time (2 calls tracked on Astrana Health, Inc.). We show the numbers — you decide.

Is it too late to buy Astrana Health, Inc.? How high can it go?

The most bullish analyst target on Astrana Health, Inc. is $65.00 (+69% above today's price); the average is $51.50. That's the upside they see. Check how reliable those analysts have actually been on Astrana Health, Inc. on our site before trusting it.

Is Astrana Health, Inc. still a good buy?

The most useful "opinion" isn't an opinion — it's a track record: 6 analysts have a real record on Astrana Health, Inc., the best hitting 100% over 2 calls. Current consensus: "Buy". Make your call on data, not noise.

Should you invest in Astrana Health, Inc.? The case for and against

The arguments for and against, one by one, from the numbers: why invest in ASTH (and why hesitate).

What has Astrana Health, Inc.'s past performance been?

Historical returns and a "how much if I had invested" calculator: ASTH performance & returns.

Other Health stocks

Go further

JPI AI Analyst AI assistant · JPI Invest
Answers based on the tool’s data · not financial advice · full version (free)